Zoetis Pre-Tax Profit Margin 2011-2021 | ZTS

Current and historical pre-tax profit margin for Zoetis (ZTS) from 2011 to 2021. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Zoetis pre-tax profit margin for the three months ending September 30, 2021 was .
Zoetis Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2021-09-30 $7.62B $2.40B 31.54%
2021-06-30 $7.41B $2.34B 31.57%
2021-03-31 $7.01B $2.19B 31.18%
2020-12-31 $6.68B $2.00B 29.90%
2020-09-30 $6.54B $2.01B 30.77%
2020-06-30 $6.34B $1.94B 30.66%
2020-03-31 $6.34B $1.92B 30.24%
2019-12-31 $6.26B $1.80B 28.77%
2019-09-30 $6.15B $1.78B 28.98%
2019-06-30 $6.05B $1.67B 27.65%
2019-03-31 $5.91B $1.65B 27.97%
2018-12-31 $5.83B $1.69B 29.01%
2018-09-30 $5.72B $1.70B 29.75%
2018-06-30 $5.59B $1.70B 30.37%
2018-03-31 $5.44B $1.61B 29.49%
2017-12-31 $5.31B $1.53B 28.74%
2017-09-30 $5.12B $1.33B 25.88%
2017-06-30 $5.02B $1.25B 24.83%
2017-03-31 $4.96B $1.23B 24.87%
2016-12-31 $4.89B $1.23B 25.12%
2016-09-30 $4.89B $1.07B 21.82%
2016-06-30 $4.86B $1.01B 20.71%
2016-03-31 $4.83B $0.65B 13.41%
2015-12-31 $4.77B $0.55B 11.44%
2015-09-30 $4.81B $0.63B 13.12%
2015-06-30 $4.81B $0.60B 12.40%
2015-03-31 $4.79B $0.82B 17.18%
2014-12-31 $4.79B $0.82B 17.14%
2014-09-30 $4.72B $0.79B 16.76%
2014-06-30 $4.61B $0.74B 16.00%
2014-03-31 $4.57B $0.73B 15.87%
2013-12-31 $4.56B $0.69B 15.13%
2013-09-30 $4.48B $0.64B 14.23%
2013-06-30 $4.40B $0.67B 15.14%
2013-03-31 $4.38B $0.73B 16.69%
2012-12-31 $4.34B $0.71B 16.37%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $106.785B $6.675B
Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $43.860B 7.18
Catalent (CTLT) United States $21.140B 40.22
Stevanato Group S.p.A (STVN) Italy $6.778B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.022B 15.73
USANA Health Sciences (USNA) United States $1.957B 15.35
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.278B 5.89
Rafael Holdings (RFL) United States $0.124B 0.00
Lannett Co Inc (LCI) United States $0.089B 0.00